Table 3.
Molecule | 4,9-O′-diacetyl sialic acid | 3,4,5-Trihydroxy-1,8-bis[(2R,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]benzo[7]annulen-6-one | Oridonin | Silymarin | Spirosolane | Withanolide D |
---|---|---|---|---|---|---|
ESOL solubility (mg/ml) | 1.24e+02 mg/ml | 5.06E−02 | 2.58E+00 | 3.46E−02 | 1.95E−05 | 1.21E−02 |
GI absorption | Low | Low | High | Low | High | High |
BBB permeant | No | No | High | Low | Yes | No |
Pgp substrate | Yes | No | No | No | No | Yes |
CYP1A2 inhibitor | No | No | Yes | No | No | No |
CYP2C19 inhibitor | No | No | No | No | No | No |
CYP2C9 inhibitor | No | No | No | No | No | No |
CYP2D6 inhibitor | No | No | No | No | No | No |
CYP3A4 inhibitor | No | No | No | Yes | No | No |
Log Kp (cm/s) | − 9.19 | − 8.47 | − 7.89 | − 3.12 | − 6.96 |